Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus

A. Shah, Manish; Kojima, Takashi; Hochhauser, Daniel; C. Enzinger, Peter; Raimbourg, Judith; Hollebecque, Antoine; Lordick, Florian; Kim, Sung‐Bae; Tajika, Masahiro; Tae Kim, Heung; Craig Lockhart, A.; Arkenau, Hendrik-Tobias; El-Hajbi, Farid; Gupta, Mukul; Pfeiffer, Per; Liu, Qi; Lunceford, Jared; Peter Kang, Soonmo; Bhagia, Pooja; Kato, Ken

doi:10.1001/jamaoncol.2018.5441

Public

Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus

Published in JAMA Oncology • Dec 20, 2018

Authors:

Manish A. Shah

Takashi Kojima

Daniel Hochhauser

Abstract

IMPORTANCE: Effective treatment options are limited for patients with advanced, metastatic esophageal cancer progressing after 2 or more lines of systemic therapy. OBJECTIVE: To evaluate the efficacy and safety of pembrolizumab for patients with advanced, metastatic esophageal squamous cell carcinom...

Subject

Medicine

Pembrolizumab

Esophagus

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!